http://rdf.ncbi.nlm.nih.gov/pubchem/reference/20144808
Outgoing Links
Predicate
Object
contentType
Journal Article
endingPage
939
issn
1792-1074
1792-1082
issueIdentifier
4
pageRange
935-939
publicationName
Oncology Letters
startingPage
935
bibliographicCitation
Yang L, Shi L, Fu Q, Xiong H, Zhang M, Yu S. Efficacy and safety of sorafenib in advanced renal cell carcinoma patients: Results from a long-term study. Oncol Lett. 2012 Apr 01;3(4):935–9. PMID: 22741022; PMCID: PMC3362461.
creator
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a32cdf858176ef1e9203ff52f39ce022
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_841480eb8a5b57624d515213150db3ad
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f749cfdca0d90dd1b6d4e4932dc98ecc
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9229079dafe7425db0a995255d1c93ab
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_292e5cbad3a5f94cd91c9ca51d150bed
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a24b4901f3a730fcf54cb340449915a8
date
2012-01-31-04:00
^^<
http://www.w3.org/2001/XMLSchema#date
>
identifier
https://doi.org/10.3892/ol.2012.585
https://pubmed.ncbi.nlm.nih.gov/PMC3362461
https://pubmed.ncbi.nlm.nih.gov/22741022
isPartOf
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/37713
https://portal.issn.org/resource/ISSN/1792-1082
https://portal.issn.org/resource/ISSN/1792-1074
language
English
source
https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title
Efficacy and safety of sorafenib in advanced renal cell carcinoma patients: Results from a long-term study
discussesAsDerivedByTextMining
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7170
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID216239
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_cad62314330b0a7a106aec2b9b6d9411
Total number of triples:
31
.